Tuesday, September 23, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyzing Southland Holdings Q4 Earnings Performance

Elaine Mendonca by Elaine Mendonca
March 4, 2024
in Breaking News
0
Home Construction Stock Exchange
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Southland Holdings Q4 Earnings Breakdown

Southland Holdings (AMEX: SLND) recently disclosed its Q4 earnings, unveiling important details for investors to take note of. Here’s a breakdown of the key highlights:

Earnings Performance:
Southland Holdings fell short of estimated earnings by -700.0%, posting an EPS of $-0.12 as opposed to an expected $0.02.
Revenue saw a significant increase of $21.39 million compared to the same period last year.

Past Earnings Performance:
In the previous quarter, the company missed EPS by $0.02, leading to a 6.0% rise in the share price the following day.
A summary of Southland Holdings’ performance in recent quarters is as follows:

Quarter EPS Estimate EPS Actual Revenue Estimate (in millions) Revenue Actual (in millions)
Q3 2023 0.10 0.08 $300.65 $312.47
Q2 2023 0.34 -0.76 $257.00 $256.93
Q1 2023 -0.04 -0.03 $237.45 $274.83
Q4 2022 0.23 0.68 $338.47 $294.80

For more in-depth information and to keep track of all earnings releases for Southland Holdings, you can visit their quarterly results page.

This summary offers a comprehensive overview of Southland Holdings’ recent financial performance, providing valuable insights for investors to understand the company’s direction and market position.

SLND Stock Plummets 5.41% in One Day – Should Investors Be Worried?

On March 4, 2024, SLND stock experienced a significant drop in its price performance. The stock closed at $4.37, which was $0.25 lower than the previous market close, representing a 5.41% decrease for the day. SLND is currently trading near the bottom of its 52-week range and below its 200-day simple moving average, indicating a downward trend. In after-hours trading, the stock dropped an additional $0.04, suggesting investors may be losing confidence and selling off shares. It is important to monitor SLND’s performance in the coming days to see if it can rebound. Exercise caution when considering buying or holding SLND stock until there is more clarity on its price momentum and market conditions.

SLND Stock Shows Impressive Growth in Net Income and Earnings per Share

On March 4, 2024, SLND stock experienced a significant increase in both net income and earnings per share compared to the previous year and quarter. According to data from CNN Money, SLND reported a net income of $1.93 million over the course of the past year, which represents a staggering 1495.06% increase from the previous year. In the third quarter of the same year, SLND’s net income rose to $3.80 million, marking a 129.63% increase from the previous quarter.

Similarly, SLND’s earnings per share (EPS) also saw substantial growth over the same period. The EPS for the past year stood at $0.05, reflecting a remarkable 1479.49% increase from the previous year. In the third quarter of the year, the EPS rose to $0.08, representing a 129.02% increase from the previous quarter.

While the total revenue for SLND is currently unavailable, the impressive growth in net income and EPS suggests that the company has been performing well financially. Investors may view these positive financial indicators as a sign of potential growth and profitability for SLND in the future.

Tags: SLND
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
DrugRetailers Stock Market Today

ThredUp Reports Strong Revenue Growth in Q4 2023 and Optimistic Outlook for 2024

Doctor on mobile phone

Health Tech Innovations: Transforming Healthcare Delivery and Monitoring

Revenue Operations: How Innovative Technology is Transforming Sales Strategies

Revenue Operations: How Innovative Technology is Transforming Sales Strategies

Recommended

Healthcare-sector

Analysts Divided on GE HealthCare Technologies Evaluating the Potential of the Stock

2 years ago
Footwear Industry Markets and money (1)

Anne Mehlman Appointed as EVP and President of Crocs Brand Search Underway for New CFO

2 years ago
Moog Stock

Security Breach at Defense Contractor Moog Highlights Sector Vulnerabilities

4 weeks ago

Malibu Boats Remains Optimistic Despite Decline in Earnings

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Can Pacific Biosciences’ New Screening Strategy Reverse Its Fortunes?

Opendoor Shares Face Reality Check as Influencer Support Shifts

Ziff Davis: Insider Confidence Clashes with Cautious Analyst Outlook

Main Capital Shares Face Pressure Despite Dividend Boost

Halozyme’s Patent Battle with Merck: A Potential Billion-Dollar Inflection Point

Seacoast Banking of Florida: A Regional Powerhouse Gaining Momentum

Trending

Unitedhealth Stock
Analysis

UnitedHealth Navigates Mounting Cost Pressures After Volatile Year

by Robert Sasse
September 23, 2025
0

UnitedHealth Group is working to regain its footing following a challenging period. The managed care giant's stock,...

BigBear.ai Stock

BigBear.ai Stock: Low Valuation Masks Deeper Fundamental Concerns

September 23, 2025
Coherus BioSciences Stock

Coherus BioSciences: A High-Stakes Pivot to Oncology

September 23, 2025
Pacific Biosciences Stock

Can Pacific Biosciences’ New Screening Strategy Reverse Its Fortunes?

September 23, 2025
Opendoor Stock

Opendoor Shares Face Reality Check as Influencer Support Shifts

September 23, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • UnitedHealth Navigates Mounting Cost Pressures After Volatile Year
  • BigBear.ai Stock: Low Valuation Masks Deeper Fundamental Concerns
  • Coherus BioSciences: A High-Stakes Pivot to Oncology

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com